Coalesce Capital Acquires Leading Healthcare IT and Business Solutions Provider DAS Health

Coalesce Capital收购领先的医疗IT和商业解决方案提供商DAS Health

NEW YORK and TAMPA, Fla., May 27, 2025-- Coalesce Capital ('Coalesce'), a private equity firm focused on investing in human capital-driven and technology-enabled services companies, today announced it has acquired a majority stake in DAS Health Ventures ('DAS Health'), a leading provider of healthcare IT and business solutions.

纽约和佛罗里达州坦帕，2025年5月27日——专注于投资于人力资本驱动和技术支持服务公司的私募股权公司Coalesce Capital（“Coalesce”）今日宣布，已收购医疗IT和商业解决方案的领先提供商DAS Health Ventures（“DAS Health”）的多数股权。

Sheridan Capital Partners ('Sheridan'), which invested in DAS Health in 2021, will retain a minority ownership position and continue to support the company's growth..

Sheridan Capital Partners（“Sheridan”）于2021年投资了DAS Health，将保留少数股权，并继续支持公司的增长。

DAS Health provides a comprehensive suite of IT, cybersecurity, revenue cycle management, and business solutions to thousands of healthcare organizations across North America, streamlining workflows, increasing productivity, and improving patient care. Coalesce will support DAS Health's growth by investing in technology, talent, and strategic acquisitions, further strengthening the company's ability to deliver value to healthcare organizations..

DAS Health 为北美数千家医疗保健机构提供全面的 IT、网络安全、收入周期管理和商业解决方案，简化工作流程、提高生产力并改善患者护理。Coalesce 将通过投资技术、人才和战略性收购来支持 DAS Health 的增长，进一步增强公司为医疗机构提供价值的能力。

'We are thrilled to welcome Coalesce Capital as we embark on this next chapter for DAS Health,' said Michelle Jaeger, President & CEO of DAS Health. 'Their investment underscores our commitment to delivering innovative solutions that help healthcare organizations operate more efficiently and improve patient care.

“我们非常高兴在DAS Health进入下一个篇章之际，欢迎Coalesce Capital的加入，”DAS Health总裁兼首席执行官米歇尔·贾格尔表示，“他们的投资彰显了我们致力于提供创新解决方案，以帮助医疗机构更高效地运营并改善患者护理。”

With Sheridan's continued support, we are well-positioned to broaden our reach and help even more providers achieve operational excellence and better outcomes.'.

在Sheridan的持续支持下，我们有能力扩大我们的影响力，帮助更多的供应商实现运营卓越和更好的成果。

'As healthcare organizations face growing challenges in patient data management, regulatory compliance, and operational demands, DAS Health stands out as a trusted partner solving these critical pain points,' said Stephanie Geveda, Founder & Managing Partner at Coalesce Capital. 'We are excited to invest in DAS Health, whose proven track record for delivering reliable, mission-critical solutions has already improved care for over 15 million patients.

“随着医疗卫生组织在患者数据管理、法规遵从性和运营需求方面面临的挑战日益增加，DAS Health 凭借解决这些关键痛点的能力脱颖而出，成为值得信赖的合作伙伴，”Coalesce Capital 创始人兼管理合伙人斯蒂芬妮·格维达 (Stephanie Geveda) 表示。“我们很高兴投资于 DAS Health，其经过验证的可靠、关键任务解决方案的交付记录已经改善了超过 1500 万患者的服务。”

We look forward to supporting their continued growth.'.

我们期待支持他们继续成长。

'DAS Health's achievements reflect the dedication of Sheridan and the entire DAS Health team, who have built a platform that addresses the most urgent needs of healthcare providers,' added Austin Heiman, Managing Director at Coalesce Capital. 'We are excited to partner with Sheridan and the team to broaden their solutions and continue to help providers navigate the increasingly complex healthcare technology landscape.'.

Coalesce Capital的董事总经理奥斯汀·海曼补充道：“DAS Health的成就反映了谢里丹和整个DAS Health团队的奉献精神，他们打造了一个解决医疗供应商最紧迫需求的平台。我们很高兴与谢里丹及其团队合作，拓展他们的解决方案，并继续帮助供应商应对日益复杂的医疗技术环境。”

'Since partnering with DAS Health in 2021, we have seen the company significantly expand its solutions and deliver increasing value to a growing client base,' said Jonathan Lewis, Partner at Sheridan. 'We are proud of the DAS Health team's progress and look forward to supporting their continued expansion alongside Coalesce to deliver even more impact for healthcare organizations.' .

Sheridan合伙人Jonathan Lewis表示：“自从2021年与DAS Health合作以来，我们已经看到该公司大幅扩展了其解决方案，并为不断增长的客户群提供了越来越多的价值。我们为DAS Health团队的进步感到自豪，并期待与Coalesce一起支持他们的持续扩展，为医疗机构带来更大的影响力。”

Houlihan Lokey served as financial advisor and McDermott Will & Emery LLP served as legal advisor to DAS Health and its shareholders. Lazard served as financial advisor and Latham & Watkins, LLP served as legal advisor to Coalesce Capital. Financial terms of the transaction were not disclosed.

霍利汉·洛基担任DAS Health及其股东的财务顾问，麦克德莫特·威尔和埃默里律师事务所担任法律顾问。拉扎德担任Coalesce Capital的财务顾问，瑞生国际律师事务所担任法律顾问。本次交易的财务条款尚未披露。

About DAS Health

关于DAS健康

DAS Health is a leading provider of healthcare IT and business solutions to independent and enterprise physician groups and healthcare systems across North America. Headquartered in Tampa, FL with regional offices in 15 US states and Canada, and an employee presence in 6 Canadian provinces and over 35 US states, DAS delivers managed IT services, cybersecurity, cloud hosting, revenue cycle management, value-based care, patient engagement, compliance, and practice management solutions impacting over 15 million patients nationwide.

DAS Health 是北美领先的医疗 IT 和商业解决方案提供商，服务于独立和企业级医生团体及医疗系统。公司总部位于佛罗里达州坦帕市，在美国 15 个州和加拿大设有区域办事处，员工遍布加拿大 6 个省和美国 35 个州以上。DAS 提供托管 IT 服务、网络安全、云托管、收入周期管理、基于价值的护理、患者参与、合规性和实践管理解决方案，影响着全美超过 1500 万名患者。

For more information, please visit www.dashealth.com..

有关更多信息，请访问 www.dashealth.com。

About Coalesce Capital

关于凝聚资本

Coalesce Capital is a private equity firm that partners with entrepreneurs and management teams to build enduring value around differentiated businesses. Coalesce has over $1.4 billion of regulatory assets under management and is dedicated to investing in human capital-driven and technology-enabled services companies.

Coalesce Capital是一家私募股权公司，与企业家和管理团队合作，围绕差异化企业构建持久价值。Coalesce管理的监管资产超过14亿美元，专注于投资于人力资本驱动和技术支持的服务公司。

The firm's growth-oriented investment philosophy centers around its conviction that people are the most important ingredient of value creation. Coalesce leverages its sector expertise, strategic resources and capital to collaborate with management teams to create shared success. For more information, please visit www.coalescecap.com.

公司的成长型投资理念围绕一个信念：人是创造价值的最重要因素。Coalesce利用其行业专业知识、战略资源和资本，与管理团队合作，共创共享成功。欲了解更多信息，请访问www.coalescecap.com。

Follow Coalesce on LinkedIn: @Coalesce..

在LinkedIn上关注Coalesce：@Coalesce。

About Sheridan Capital Partners

关于谢里登资本合伙公司

Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, and strives to bring strategic resources to accelerate growth, build enduring value, and achieve strong results.

Sheridan Capital Partners是一家位于芝加哥的医疗保健私募股权公司，专注于美国和加拿大的中低端市场收购和成长型股权投资。Sheridan与医疗服务提供商及其服务、医疗IT及外包服务、消费健康和医疗产品等垂直领域的公司合作，致力于带来战略资源以加速增长、创造持久价值并取得强劲业绩。

For more information, please visit www.sheridancp.com..

欲了解更多信息，请访问www.sheridancp.com。

Contact:

联系人：

Media Contact

媒体联系人

Ed Trissel / Sarah Salky / Kate Thompson

埃德·特里塞尔 / 萨拉·萨尔基 / 凯特·汤普森

Joele Frank, Wilkinson Brimmer Katcher

乔勒·弗兰克，威尔金森·布里默·卡彻

212-355-4449

212-355-4449

Coalesce-JF@joelefrank.com

合并-JF@joelefrank.com